Aurinia Pharmaceuticals Inc AUPH
16.44
(0.16)
(0.96%)
as of 25 Sep
- Market cap
- $2.2B
- P/E
- 6.9×
Follow AUPH
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 66.12% | 64.98% | 59.91% | 20.65% |
+8 more TTM periods Free account |
|
| 48.52% | 48.54% | 44.11% | 14.46% | ||
ROIC |
40.76% | 34.24% | 30.35% | 71.84% | |
Return on Tangible Assets |
70.86% | 75.37% | 71.74% | 21.34% | |
Average Days of Receivables |
48.20 | 60.17 | 53.46 | 42.19 | |
Free Cash Flow per Share |
1.35 | 1.26 | 1.01 | 0.91 | |
Free Cash Flow |
175.07 | 166.64 | 135.41 | 119.87 | |
Capital Expenditures |
(0.18) | (0.27) | (0.25) | (0.24) | |
Piotroski F-Score |
6.00 | 6.00 | 7.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
15.90% | 16.78% | 13.15% | 15.53% | |
Accounts Receivable Turnover |
7.67 | 6.66 | 7.26 | 7.91 | |
Accounts Payable Turnover |
11.90 | 8.89 | 7.69 | 1.00 | |
Inventory Turnover |
0.66 | 0.66 | 0.77 | 0.70 | |
Average Days of Payables |
21.08 | 31.74 | 37.02 | 27.47 | |
Days of Inventory on Hand |
548.68 | 553.66 | 510.54 | 555.76 | |
Tax Rate |
0.96 | 1.23 | 1.52 | (0.02) | |
Research and Development Expense of Revenue |
12.79% | 11.48% | 11.48% | 11.18% | |
Selling, General and Administrative Expense of Revenue |
32.41% | 34.69% | 35.96% | 41.22% | |
Share Based Compensation of Revenue |
4.69% | 5.77% | 5.19% | 6.36% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.56 | 0.56 | 0.47 | 1.54 | |
Depreciation/Fixed assets |
10.41 | 9.77 | 9.21 | 8.58 | |
Capex/Depreciation |
(0.01) | (0.01) | (0.01) | (0.01) | |
Revenue per Share |
2.39 | 2.25 | 2.11 | 2.02 | |
Operating CF per Share |
1.35 | 1.26 | 1.01 | 0.91 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
100.84% | 99.97% | 101.47% | 29.28% |
Columns are period end dates